Actively Recruiting
Forced Oscillations Technique During a Metacholine Test in Children
Led by University Hospital, Montpellier · Updated on 2023-09-13
112
Participants Needed
1
Research Sites
172 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Asthma is the most common chronic lung disease in children. It affects more than 1 in 10 children in France. The methacholine bronchial challenge test (MBT) is indicated to assess the probability of asthma suggested by clinical symptoms by measuring the forced expiratory volume in one second (FEV1), after inhalation of a cumulative dose of methacholine. In children, the measurement of FEV1 requires a high level of cooperation from the child, which can be the source of false negatives or no result if this is not obtained. The objective of this study is to evaluate if the measurement of the respiratory function by the forced oscillations technique, allows to predict the variation of the FEV1 obtained
CONDITIONS
Official Title
Forced Oscillations Technique During a Metacholine Test in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 6 and 16 years
- Forced expiratory volume in one second (FEV1) greater than 60%
- Child referred for a methacholine bronchial challenge test to evaluate nonspecific bronchial hyperactivity
- Child stopped inhaled corticosteroid treatment for at least 3 weeks
- Oral consent given by the child and at least one legal representative
- Child covered by or benefiting from a social security plan
You will not qualify if you...
- Use of short-acting beta-adrenergic bronchodilator within 6 hours or anticholinergic bronchodilator within 12 hours
- Use of long-acting beta-adrenergic bronchodilator approved for children within the past 36 hours
- Upper or lower respiratory tract infection within 3 weeks prior to inclusion
- Epilepsy under treatment
- Participation in another interventional study that may affect respiratory function
- Patient unable to give consent or considered vulnerable
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Montpellier
Montpellier, France
Actively Recruiting
Research Team
S
Stefan MATECKI, MD
CONTACT
A
Anne REQUIRAND
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here